A Trial of SHR-1701 With or Without Chemotherapy in Patients With Stage III NSCLC

NCT04580498 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

107

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-Small-Cell Lung Cancer

Interventions

DRUG: SHR-1701+Paclitaxel+carboplatin
DRUG: SHR-1701

Sponsor

Jiangsu HengRui Medicine Co., Ltd.